Mark Stow
Impact in
- Biotechnology top 10%
- Transgenic Plants and Applications
-
- Protease and Inhibitor Mechanisms
Papers in
-
- Bone Metabolism and Diseases 2
- Peroxisome Proliferator-Activated Receptors 1
- Gene expression and cancer classification 1
- Oncology 3
- Bone health and treatments 2
- Co-authors
- Adrienne M. Flanagan (2 shared papers)Vidadi Yusibov (1 shared paper)Stephen J. Streatfield (1 shared paper)R. Mark Jones (1 shared paper)Brian J. Green (1 shared paper)George I. Moonsammy (1 shared paper)Jessica A. Chichester (1 shared paper)Ashfaq A. Parkar (2 shared papers)
- Journals
- Clinical & Experimental Immunology (1 paper)Protein Expression and Purification (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Journal of Immunological Methods (1 paper)The Journal of Pathology (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Stow
8 papers receiving 161 citations
Peers
Comparison fields: 5 of 48
- Biotechnology 51
- Cancer Research 34
- Hematology 16
- Oncology 37
- Molecular Biology 93
Countries citing papers authored by Mark Stow
This map shows the geographic impact of Mark Stow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stow more than expected).
Fields of papers citing papers by Mark Stow
This network shows the impact of papers produced by Mark Stow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stow. The network helps show where Mark Stow may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Stow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 62 | |
| 2 | 2000 | 30 | |
| 3 | 2002 | 20 | |
| 4 | 1995 | 16 | |
| 5 | The role of 1,25-dihydroxycholecalciferol and prostaglandin E2 in the regulation of human osteoclastic bone resorption in vitro. | 1995 | 14 |
| 6 | 1993 | 13 | |
| 7 | 2003 | 12 | |
| 8 | 2001 | 9 |
About Mark Stow
Mark Stow is a scholar working on Molecular Biology, Oncology, Hematology, Cancer Research and Infectious Diseases, having authored 8 papers that have together received 176 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (2 papers), Bone health and treatments (2 papers), Folate and B Vitamins Research (1 paper), Bone and Joint Diseases (1 paper), Peroxisome Proliferator-Activated Receptors (1 paper), Gene expression and cancer classification (1 paper), Amino Acid Enzymes and Metabolism (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Biotechnology (51 citations), Cancer Research (34 citations), Hematology (16 citations), Oncology (37 citations) and Molecular Biology (93 citations). Mark Stow has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Adrienne M. Flanagan, Vidadi Yusibov, Stephen J. Streatfield, R. Mark Jones, Brian J. Green, George I. Moonsammy, Jessica A. Chichester, Ashfaq A. Parkar, Richard Williams and Keith Smith. Their work appears in journals such as Clinical & Experimental Immunology, Protein Expression and Purification, Journal of Pharmacology and Experimental Therapeutics, Journal of Immunological Methods and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.